Trial intelligence / Profile preview

Effect of Immunotherapy on Children with Rhinitis and Asthma due to House Dust Mite Allergy

TCTR20250626003Phase 3Recruiting

Sponsor
Universitas Airlangga
Start
Jun 2025
Countries
1
01

Overview

Phase 3 trial in allergic rhinitis (AR), asthma and house dust mite allergy (2 arms), sponsored by Universitas Airlangga. Started Jun 2025; status: recruiting.

02

Conditions

allergic rhinitis (AR)asthmahouse dust mite allergy

Beyond the preview

Go deeper on TCTR20250626003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250626003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call